Clinical Social Workers in Osage Beach, MO Accepting Medicare
3 Clinical Social Workers found. Showing 1 - 3
 Amy M Blake, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 980 Parkside Village Ln, Osage Beach, MO 65065 Phone: 884-031-0718 Fax: 573-302-7369 |
Mrs. Suzanne Marie Mericle, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1191 State Highway Kk, Suite 101, Osage Beach, MO 65065 Phone: 573-302-7241 |
Theresa Welch, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1191 State Hwy Kk, Suite 101, Osage Beach, MO 65065 Phone: 573-302-7241 Fax: 573-302-7239 |
News Archive
Moderate alcohol consumption may reduce risk of kidney cancer
A majority of previous epidemiologic studies have shown that moderate drinking is associated with a lower risk of kidney cancer, which may affect about 1% of the general population. In published prospective cohort studies, the risk for such cancer among moderate drinkers is usually about 25% less than the risk seen among non-drinkers.
New study reveals doctors less likely to seek help for their own mental health issues
Even as doctors across America encourage their patients to share concerns about depression, anxiety and other concerns, so they can get help from modern treatments, a new study suggests the doctors may be less likely to seek help for those same concerns about themselves.
pSivida reports interim results of human PK study of Iluvien
pSivida Corp, a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today reported the interim 18-month safety and efficacy results from the first human pharmacokinetic study (PK Study) of Iluvien®. The PK trial is being conducted by Alimera Sciences, the licensee for Iluvien.
BD Diagnostics receives FDA approval for imaging system that enhances detection of cervical cancer
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) has announced that it received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the BD FocalPoint(TM) GS Imaging System.
› Verified 8 days ago
Pharmacists
Counselors
Occupational Therapists
Dentists
Psychologists
Clinical Social Workers